Evidence map›Paper›PMID 41995096›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Engineering Microbial Particles for Next-Generation Biomedical Platforms.

Yuting Li, Yunjie Lu, Ziyan Huang, Jianjiang Chen, Yanbin Liu, Lei Qin, Chao Wang, Yumin Wu

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuting LiDepartment of Hepatobiliary Surgery, Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Yunjie LuDepartment of Hepatobiliary Surgery, Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Ziyan HuangDepartment of Hepatobiliary Surgery, Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Jianjiang ChenState Key Laboratory of Targeting Oncology, Guangxi Medical University, Nanning, Guangxi, China.
Yanbin LiuInstitute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu, China.
Lei QinDepartment of Hepatobiliary Surgery, Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.
Chao WangInstitute of Functional Nano & Soft Materials (FUNSOM), Soochow University, Suzhou, Jiangsu, China.ORCID https://orcid.org/0000-0002-8054-3472
Yumin WuDepartment of Hepatobiliary Surgery, Department of General Surgery, The First Affiliated Hospital of Soochow University, Suzhou, China.

Funding

National Natural Science Foundation of China U25A20599Natural Science Foundation of Jiangsu Province BK20255001
6 · The paper itself

Abstract

Microbe-derived particles (MDPs), which include extracellular vesicles, outer membrane vesicles, inclusion bodies, polysaccharide particles, and virus-like particles, represent a rapidly expanding category of bioinspired nanomaterials. With their natural origin, intrinsic biocompatibility, and highly programmable functionality, MDPs serve as a versatile bridge between living microbial systems and engineered nanomaterials. This review systematically outlines the diverse classes, biosynthetic pathways, physicochemical properties, and biomedical applications of MDPs. We summarize recent progress in their use for drug delivery, vaccine design, immune modulation, and diagnostic imaging, emphasizing how bioengineering approaches enable precise control over their composition and targeting capabilities. Additionally, we examine advancing methodologies for scalable manufacturing and accurate characterization-such as omics-based profiling and advanced imaging techniques. Finally, we discuss current challenges and future prospects for integrating synthetic biology with materials science to develop next-generation intelligent biological platforms based on MDPs. This comprehensive overview aims to foster the rational design and translational deployment of MDP-based systems across biomedical, biotechnological, and materials science fields.

Indexed as

biomedical engineeringintelligent biological platformmicrobe‐derived particles

Identifiers

PMID41995096
PMCPMC13335627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.